• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺激素受体α调节肝星状细胞中的纤维化。

Thyroid hormone receptor alpha modulates fibrogenesis in hepatic stellate cells.

机构信息

Department of Internal Medicine, University Hospital Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany.

Division of Gastroenterology and Hepatology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.

出版信息

Liver Int. 2024 Jan;44(1):125-138. doi: 10.1111/liv.15759. Epub 2023 Oct 23.

DOI:10.1111/liv.15759
PMID:37872645
Abstract

OBJECTIVE

Progressive hepatic fibrosis can be considered the final stage of chronic liver disease. Hepatic stellate cells (HSC) play a central role in liver fibrogenesis. Thyroid hormones (TH, e.g. thyroxine; T4 and triiodothyronine; T3) significantly affect development, growth, cell differentiation and metabolism through activation of TH receptor α and/or β (TRα/β). Here, we evaluated the influence of TH in hepatic fibrogenesis.

DESIGN

Human liver tissue was obtained from explanted livers following transplantation. TRα-deficient (TRα-KO) and wild-type (WT) mice were fed a control or a profibrogenic methionine-choline deficient (MCD) diet. Liver tissue was assessed by qRT-PCR for fibrogenic gene expression. In vitro, HSC were treated with TGFβ in the presence or absence of T3. HSC with stable TRα knockdown and TRα deficient mouse embryonic fibroblasts (MEF) were used to determine receptor-specific function. Activation of HSC and MEF was assessed using the wound healing assay, Western blotting, and qRT-PCR.

RESULTS

TRα and TRβ expression is downregulated in the liver during hepatic fibrogenesis in humans and mice. TRα represents the dominant isoform in HSC. In vitro, T3 blunted TGFβ-induced expression of fibrogenic genes in HSC and abrogated wound healing by modulating TGFβ signalling, which depended on TRα presence. In vivo, TRα-KO enhanced MCD diet-induced liver fibrogenesis.

CONCLUSION

These observations indicate that TH action in non-parenchymal cells is highly relevant. The interaction of TRα with TH regulates the phenotype of HSC via the TGFβ signalling pathway. Thus, the TH-TR axis may be a valuable target for future therapy of liver fibrosis.

摘要

目的

进行性肝纤维化可被视为慢性肝病的终末期。肝星状细胞(HSC)在肝纤维化发生中起核心作用。甲状腺激素(TH,如甲状腺素;T4 和三碘甲状腺原氨酸;T3)通过激活 TH 受体 α 和/或 β(TRα/β),对发育、生长、细胞分化和代谢产生显著影响。在这里,我们评估了 TH 对肝纤维化的影响。

设计

肝组织取自肝移植后切除的肝脏。TRα 缺陷(TRα-KO)和野生型(WT)小鼠分别给予对照或致纤维化蛋氨酸-胆碱缺乏(MCD)饮食。采用 qRT-PCR 检测纤维化基因表达,评估肝组织。体外,用 TGFβ 处理 HSC,同时或不添加 T3。使用稳定敲低 TRα 和缺乏 TRα 的小鼠胚胎成纤维细胞(MEF),确定受体特异性功能。通过划痕愈合试验、Western blot 和 qRT-PCR 评估 HSC 和 MEF 的激活。

结果

在人类和小鼠肝纤维化过程中,TRα 和 TRβ 在肝组织中的表达下调。TRα 是 HSC 中的主要异构体。体外,T3 减弱了 TGFβ 诱导的 HSC 纤维化基因表达,并通过调节 TGFβ 信号通路,阻断了划痕愈合,这取决于 TRα 的存在。在体内,TRα-KO 增强了 MCD 饮食诱导的肝纤维化。

结论

这些观察结果表明,非实质细胞中的 TH 作用非常重要。TRα 与 TH 的相互作用通过 TGFβ 信号通路调节 HSC 的表型。因此,TH-TR 轴可能是肝纤维化未来治疗的一个有价值的靶点。

相似文献

1
Thyroid hormone receptor alpha modulates fibrogenesis in hepatic stellate cells.甲状腺激素受体α调节肝星状细胞中的纤维化。
Liver Int. 2024 Jan;44(1):125-138. doi: 10.1111/liv.15759. Epub 2023 Oct 23.
2
Thyroid hormones induce activation of rat hepatic stellate cells through increased expression of p75 neurotrophin receptor and direct activation of Rho.甲状腺激素通过增加 p75 神经营养因子受体的表达和直接激活 Rho 诱导大鼠肝星状细胞的激活。
Lab Invest. 2010 May;90(5):674-84. doi: 10.1038/labinvest.2010.48. Epub 2010 Mar 15.
3
Canonical and Noncanonical Contribution of Thyroid Hormone Receptor Isoforms Alpha and Beta to Cardiac Hypertrophy and Heart Rate in Male Mice.甲状腺激素受体异构体 α 和 β 对雄性小鼠心脏肥大和心率的经典和非经典作用。
Thyroid. 2024 Jun;34(6):785-795. doi: 10.1089/thy.2023.0683. Epub 2024 Jun 3.
4
Thyroid hormone receptor-specific interactions with steroid receptor coactivator-1 in the pituitary.甲状腺激素受体与垂体中类固醇受体辅激活因子-1的特异性相互作用。
Mol Endocrinol. 2003 May;17(5):882-94. doi: 10.1210/me.2002-0174. Epub 2003 Feb 6.
5
Specificity of thyroid hormone receptor subtype and steroid receptor coactivator-1 on thyroid hormone action.甲状腺激素受体亚型和类固醇受体辅激活因子-1对甲状腺激素作用的特异性。
Am J Physiol Endocrinol Metab. 2003 Jan;284(1):E36-46. doi: 10.1152/ajpendo.00226.2002. Epub 2002 Sep 17.
6
Coordinated signaling of activating transcription factor 6α and inositol-requiring enzyme 1α regulates hepatic stellate cell-mediated fibrogenesis in mice.激活转录因子 6α 和肌醇需求酶 1α 的协调信号转导调控小鼠肝星状细胞介导的肝纤维化。
Am J Physiol Gastrointest Liver Physiol. 2021 May 1;320(5):G864-G879. doi: 10.1152/ajpgi.00453.2020. Epub 2021 Mar 17.
7
Comparative Phenotyping of Mice Reveals Canonical and Noncanonical Physiological Functions of TRα and TRβ.比较表型分析揭示了 TRα 和 TRβ 的经典和非经典生理功能。
Endocrinology. 2024 Jul 1;165(8). doi: 10.1210/endocr/bqae067.
8
Increased sensitivity to thyroid hormone in mice with complete deficiency of thyroid hormone receptor alpha.甲状腺激素受体α完全缺乏的小鼠对甲状腺激素的敏感性增加。
Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):349-54. doi: 10.1073/pnas.98.1.349.
9
Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.骨桥蛋白是瘦素介导的非酒精性脂肪性肝炎(NASH)纤维化的近端效应因子。
Biochim Biophys Acta. 2016 Jan;1862(1):135-44. doi: 10.1016/j.bbadis.2015.10.028. Epub 2015 Oct 31.
10
Thyroid hormone receptor alpha plays an essential role in the normalisation of adult-onset hypothyroidism-related hypoexpression of synaptic plasticity target genes in striatum.甲状腺激素受体α在成年期甲状腺功能减退症相关的纹状体突触可塑性靶基因低表达的正常化过程中起着至关重要的作用。
J Neuroendocrinol. 2009 Jan;21(1):49-56. doi: 10.1111/j.1365-2826.2008.01802.x.

引用本文的文献

1
Targeting Hepatic Stellate Cells for the Prevention and Treatment of Liver Cirrhosis and Hepatocellular Carcinoma: Strategies and Clinical Translation.靶向肝星状细胞预防和治疗肝硬化及肝细胞癌:策略与临床转化
Pharmaceuticals (Basel). 2025 Mar 31;18(4):507. doi: 10.3390/ph18040507.
2
A Markov Model Unveiling the Impact of Resmetirom on the Natural History of MASLD Patients: A Sistematic Review and Meta-Analysis.揭示瑞美鲁肽对非酒精性脂肪性肝炎相关肝脂肪变性(MASLD)患者自然病程影响的马尔可夫模型:一项系统评价和荟萃分析。
Liver Int. 2025 Apr;45(4):e70056. doi: 10.1111/liv.70056.
3
Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions.
慢性肝病中肝星状细胞的代谢:新出现的分子和治疗干预措施。
Theranostics. 2025 Jan 2;15(5):1715-1740. doi: 10.7150/thno.106597. eCollection 2025.
4
Revisiting the relationship between thyroid function and metabolic dysfunction-associated steatotic liver disease in the era of resmetirom.在resmetirom时代重新审视甲状腺功能与代谢功能障碍相关脂肪性肝病之间的关系。
J Gastroenterol. 2025 Mar;60(3):389-391. doi: 10.1007/s00535-025-02214-2. Epub 2025 Jan 23.
5
Actions of thyroid hormones and thyromimetics on the liver.甲状腺激素和拟甲状腺药物对肝脏的作用。
Nat Rev Gastroenterol Hepatol. 2025 Jan;22(1):9-22. doi: 10.1038/s41575-024-00991-4. Epub 2024 Oct 17.
6
Casual associations of thyroid function with inflammatory bowel disease and the mediating role of cytokines.甲状腺功能与炎症性肠病的偶然关联及细胞因子的介导作用。
Front Endocrinol (Lausanne). 2024 May 30;15:1376139. doi: 10.3389/fendo.2024.1376139. eCollection 2024.